S. 2669 · 115th Congress
Advancing Innovation in Alternative Pain and Addiction Therapies Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
HatchSponsor4 cosponsors · 2 D, 2 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Advancing Innovation in Alternative Pain and Addiction Therapies Act
What it does: CRS summary · Introduced in Senate · Apr 16, 2018
Advancing Innovation in Alternative Pain and Addiction Therapies Act
This bill requires the Food and Drug Administration to issue guidance clarifying eligibility and criteria for the accelerated approval of non-opioid or nonaddictive drugs to treat pain or substance-use disorders.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Advancing Innovation in Alternative Pain and Addiction Therapies Act
Latest action (Apr 16, 2018): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Apr 16, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.